Remifentanil on Post-Operative Analgesic Consumption Following Shoulder Arthroplasty .
Effect of remifentanil on post-operative analgesic consumption in patients undergoing shoulder arthroplasty after interscalene brachial plexus block: a randomized controlled trial
J Anesth . 2022 Aug;36(4):506-513.Sixty-eight patients undergoing arthroscopic repair for rotator cuff tears with an interscalene brachial plexus block were randomized to receive either remifentanil intraoperatively (n=34) or no analgesics intraoperatively (n=34). The primary outcome of this trial was the dose of fentanyl-nefopam IV-PCA postoperatively over 24 hours. Secondary outcomes such as the amount of rescue analgesics, total morphine milligram equivalents, attempted PCA bolus, and pain scores were assessed. Significantly lower fentanyl and nefopam consumption along with PCA bolus attempts and total analgesics consumption were reported in the control group postoperatively as compared to the remifentanil group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
